The terminal Schwann cell (tSC), a type of nonmyelinating Schwann cell, is a significant yet relatively understudied component of the neuromuscular junction. In addition to reviewing the role tSCs play on formation, maintenance, and remodeling of the synapse, we review studies that implicate tSCs in neuromuscular diseases including spinal muscular atrophy, Miller-Fisher syndrome, and amyotrophic lateral sclerosis, among others. We also discuss the importance of these cells on degeneration and regeneration after nerve injury. Knowledge of tSC biology may improve our understanding of disease pathogenesis and help us identify new and innovative therapeutic strategies for the many patients who suffer from neuromuscular disorders and nerve injuries.
teloglia) are nonmyelinating SCs that reside at the neuromuscular junction (NMJ), and are the focus of this review.
The NMJ is a synapse that transmits signals from motor neurons and their axons to the target muscle. It is composed of four main elements: (a) presynaptic terminal nerve, (b) synaptic basal lamina that occupies the synaptic cleft, (c) postsynaptic region of the myofiber rich in acetylcholine receptors (AChRs), and (d) tSCs (Figure 2 ). Depending on muscle fiber type (slow or fast twitch), there are typically one to three tSCs per NMJ that are connected by cytoplasmic extensions, although higher numbers of three to five tSCs per NMJ have been historically described (Balice-Gordon & Lichtman, 1990) . Immunohistochemically, tSCs can be easily identified by staining with S100b antibody, a marker of all SCs, both myelinating and nonmyelinating ( Figure 2 ). While relatively less is known about tSCs compared with the other NMJ components, they are integral contributors to the development, maintenance, and regeneration of the synapse (Feng & Ko, 2008; Kang, Tian, Mikesh, Lichtman, & Thompson, 2014; Macleod, Dickens, & Bennett, 2001; O'Malley, Waran, & Balice-Gordon, 1999; Reist & Smith, 1992; Son & Thompson, 1995a , 1995b Son, Trachtenberg, & Thompson, 1996) .
| tSCs in NMJ synaptogenesis
Although not necessary for initial NMJ formation, tSCs play a vital role in the growth and maintenance of the synapse during development (Darabid, Perez-Gonzalez, & Robitaille, 2014; Kullberg, Lentz, & Cohen, 1977; Lin et al., 2000; Linden & Letinsky, 1988; Woldeyesus et al., 1999 ). Herrera et al. studied the roles that tSCs play in amphibian NMJ development (Herrera, Qiang, & Ko, 2000) . Their results demonstrate that in the first phase of amphibian NMJ development, tSCs occupy most NMJs but only partially cover the synapse. In the second stage, tSCs begin to extend cytoplasmic processes, and numbers of tSCs at the NMJ increase. During this phase, the presynaptic nerve terminal is tightly apposed to AChRs on the end-target muscle, and muscle fibers proliferate, but there is no evidence of NMJ or muscle growth. tSCs then maximally extend processes and cover all synaptic elements in the next stage, while NMJ length (referring to AChR labeling of synaptic gutters) increases. New NMJs do not initiate growth until full tSC occupation and cytoplasmic process extension are present. In phase 4, tSC cytoplasmic processes decrease as muscle fiber growth decreases and NMJ growth continues. By the fifth stage, the NMJ has achieved its adult form. tSC process extension is rare (Herrera et al., 2000) .
In rat NMJ development, half of the NMJs are covered by one tSC, and the other half are covered only by SC processes (Love & Thompson, 1998) . The fastest rate of tSC gain at the NMJ occurs within the first two postnatal weeks, preceding the maturation of the motor endplate. tSCs are gained via both mitosis and migration, and their final number per NMJ depends on the specific muscle. During the period of polyinnervation of the developing NMJ (discussed below), an average of 1.6 tSCs are present at the NMJ, compared with 2.7 tSCs per NMJ during the monoinnervation phase (Darabid, Arbour, & Robitaille, 2013) . By 2 months of age, tSC processes have retracted, and two to three tSCs cap the NMJ (Love & Thompson, 1998) .
In a process termed synaptic elimination, tSCs directly compete with the receptive surface of the end-target muscle to transition from polyneuronal innervation, in which multiple presynaptic motor neurons contact the AChRs at one motor endplate, to mononeuronal NMJ innervation. At P7-8 in murine NMJ development, more than 60% of NMJs are polyinnervated (Darabid et al., 2013) . tSCs extend finger-like processes between adjacent nerve terminals and between the nerve terminals and muscle fibers, competing for AChR binding sites.
Subsequently, tSCs randomly phagocytose nerve terminals that contact AChRs, promoting mononeuronal innervation (Smith, Mikesh, Lee, & Thompson, 2013) . Single tSCs have also been shown to decipher the strength of individual synaptic activity during synaptic competition and influence synaptic elimination (Darabid et al., 2013) . Synaptic elimination has been noted to occur at the period of greatest tSC occupation at the NMJ in amphibians (Herrera et al., 2000) and mammals (Love & Thompson, 1998) . A recent study supports these findings and suggests that tSC phagocytic roles are induced by neuronal expression of Neuregulin1 (Lee et al., 2016) .
Interruption or loss of any NMJ component during development is detrimental. Neonatal NMJ denervation results in tSC apoptosis . When tSCs are ablated in amphibians during NMJ development, nerve terminals retract, synaptic addition and growth decrease, and the synapse retracts (Reddy, Koirala, Sugiura, Herrera, & Ko, 2003) . However, when GGF2, the soluble form of neuregulin (NRG), is applied to tSCs after NMJ denervation in development, cells are rescued from apoptosis . NRGs are trophic factors that are present in developing motor neurons and have been shown to bind erbB3 receptors expressed on tSCs to prevent apoptotic death of SC precursors, stimulate SC DNA synthesis, and support long-term survival of SC precursors (Dong et al., 1995; Lin et al., 2000; Mahanthappa, Anton, & Matthew, 1996; Trinidad, Fischbach, & Cohen, 2000) .
These findings provide evidence that tSCs are necessary for NMJ stability during development and synaptic elimination during synaptogenesis. Furthermore, these studies suggest that trophic interactions are important to NMJ development.
| tSCs in synaptic modulation and plasticity
Multiple studies have demonstrated that tSCs sense synaptic activity and, in response, modulate synaptic transmission to ensure appropriate signal strength and efficacy at the NMJ. The first of these studies were published in 1992 by Jaromi et al. and Reist & Smith, revealing that tSCs respond to synaptic activity (Jahromi, Robitaille, & Charlton, 1992; Reist & Smith, 1992) . Both groups found that after presynaptic nerve stimulation at amphibian NMJs, there is increased intracellular calcium in tSCs. This rise in tSC intracellular calcium is blocked when neurotransmitter release from presynaptic nerves is blocked (Jahromi et al., 1992; Reist & Smith, 1992) . Additionally, trains of nerve stimulation result in smaller calcium responses in tSCs (Jahromi et al., 1992; Reist & Smith, 1992) . These findings are similar to studies performed at mammalian tSCs, although mammalian tSCs display the calciumdependent calcium-release phenomenon that is absent in amphibian NMJs (Rochon, Rousse, & Robitaille, 2001 ). Subsequent studies performed by Robitaille's group revealed that the neurotransmitters released by the presynaptic nerve that are responsible for the increase in tSC intracellular calcium are adenosine triphosphate (ATP); its degradation product, adenosine; acetylcholine; and substance P (Bourque & Robitaille, 1998; Georgiou, Robitaille, & Charlton, 1999; Robitaille, 1995; Robitaille, Jahromi, & Charlton, 1997) . These studies were conducted in amphibians, but many of the same findings were | 1127 corroborated, with slight variations, in mammalian studies (Rochon et al., 2001) . One key difference between the mammalian and amphibian NMJs is the neurotransmitter receptors expressed by tSCs. Mammalian tSCs express muscarinic acetylcholine receptors (mAChRs) that are atropine-sensitive, A1 receptors for adenosine, and an unidentified, suramin-insensitive, purinergic receptor (Rochon et al., 2001) . Recent studies have also suggested the possibility of P2y receptor expression on mammalian tSC during development, but not adulthood (Arbour, Tremblay, Martineau, Julien, & Robitaille, 2015; Darabid et al., 2013) . tSCs express mAChRs that are atropine-insensitive and, therefore, are not of the typical M1-M5 phenotype. Additionally, amphibian tSCs express A1 receptors for adenosine and P2x and P2y receptors for ATP (Robitaille, 1995; Robitaille et al., 1997; Rochon et al., 2001 ).
In addition to sensing synaptic transmission, tSCs play an important role in modulating synaptic activity. Using amphibian NMJs, it has been shown that tSC G-protein activation results in synaptic depression and decreased neurotransmitter release from the presynaptic nerve (Robitaille, 1998) . Furthermore, synaptic depression initiated by the tSCs is not continuous but, rather, occurs during high-frequency presynaptic nerve activity. These findings suggest that tSCs sense variations in synaptic activity and are able to modulate synaptic transmission, with the ultimate effect of decreasing the efficacy and strength of the synapse in response to high-frequency stimulation (Robitaille, 1998) . tSCs may modulate synaptic potentiation or depression, based on the synaptic activity profile. In response to continuous presynaptic nerve stimulation, tSCs respond with a phasic calcium response and a subsequent cascade of events that ultimately results in synaptic potentiation (Todd, Darabid, & Robitaille, 2010) . Additionally, tSCs respond with an oscillatory calcium response and a subsequent cascade of events that ultimately results in synaptic depression, in response to burst presynaptic nerve stimulation (Todd et al., 2010) . tSCs release ATP, which is degraded into adenosine and then activates presynaptic A2a or A1 receptors (Todd et al., 2010) . This study provides evidence for a model of balancing synaptic depression and potentiation at the NMJ. tSCs have the ability, therefore, to decode presynaptic nerve activity and provide appropriate acute feedback relevant to current synaptic activity (Robitaille, 1998; Todd et al., 2010) . tSCs also affect synaptic activity by modulating neurotransmitter release at the NMJ.
One proposed hypothesis for the mechanisms underlying modulation of neurotransmitter release is tSC calcium response, or release of internal calcium stores from tSCs, which is necessary for release of an unidentified secondary messenger. Both release of tSC intracellular calcium and entry of extracellular calcium into the nerve terminal are required for neurotransmitter release modulation (Castonguay & Robitaille, 2001 ). Release of glutamate from tSCs, activating metabotropic glutamate receptors on the end-target muscle, is another proposed mechanism. In response to activation, the end-target muscle releases a chemical messenger that binds the presynaptic nerve, resulting in decreased presynaptic neurotransmitter release (Pinard, Levesque, Vallee, & Robitaille, 2003) . These studies reveal that tSCs are highly plastic, respond to synaptic activity, and participate in bidirectional modification: from synapse to tSC and tSC to synapse (Belair, Vallee, & Robitaille, 2010).
| tSCs in NMJ maintenance
tSCs have been demonstrated to be essential in maintaining the adult NMJ. A study conducted by Reddy and colleagues investigated the effects of tSC ablation at adult amphibian NMJs .
Ablation of tSCs was achieved via immune-mediated cell lysis. Adult frogs were injected locally at the end-target muscle with mAb 2A12, a monoclonal antibody that selectively recognizes the surface of tSCs.
One day later, these muscles were injected with guinea pig complement serum, resulting in selective, complement-mediated cell lysis of tSCs . After acute tSC ablation, presynaptic nerve and muscle structure were unaltered, without evidence of nerve retraction or sprouting. Synaptic transmission was unchanged, with the frequency and amplitude of mepps (miniature end-plate potential), paired pulse facilitation, and synaptic depression showing no difference compared with pre ablation, suggesting that tSCs may not acutely modulate synaptic transmission. These findings are contrary to the results published by Robitaille and by Todd and colleagues discussed earlier in this review, which suggest that tSCs sense synaptic activity and provide timely, appropriate feedback to modulate synaptic transmission (Robitaille, 1998; Todd et al., 2010) . Recent studies suggest that tSCs have the ability to both potentiate and depress synaptic activity (Ko & Robitaille, 2015) . In the setting of tSC ablation, therefore, loss of both potentiation and depression could have a null effect on synaptic transmission in the acute setting (Ko & Robitaille, 2015) .
At 1 week post tSC ablation, nerve terminals begin to retract, neurotransmitter release from the presynaptic nerve decreases, and muscle contraction deficits are present, suggesting that tSCs are essential for long-term stability and maintenance of the adult amphibian NMJ . Additionally, studies have shown that through the extension and regression of tSC processes, tSCs are constantly remodeling nerve terminals in amphibians in vivo (Dickens, Hill, & Bennett, 2003; Macleod et al., 2001) . Continuous remodeling in frogs is dissimilar to findings in mammals, where mammalian NMJs are remarkably stable and exhibit little remodeling (Lichtman, Magrassi, & Purves, 1987; Wigston, 1989) . Regardless of the remodeling differences between amphibian and mammalian NMJs, tSCs play a vital role in adult NMJ maintenance and remodeling.
| tSCs and peripheral nerve injury (degeneration and regeneration)
Peripheral nerve injuries are common, accounting for 5% of all trauma patients presenting to hospitals in North America (Noble, Munro, Prasad, & Midha, 1998) . While over 50,000 peripheral nerve repair procedures are performed each year (Evans, 2001 ), the outcomes for many patients remain poor in that only 10% to 40% of all patients ever regain baseline normal function (Portincasa et al., 2007; Scholz et al., 2009 ). Native muscle reinnervation following nerve injury is possible only during a critical window of time, approximately 12 to 18 months after nerve injury (Boyd, Nimigan, & Mackinnon, 2011; Lee & Wolfe, 2012) . Beyond this time interval, communication between the regenerating nerve and end-target muscle is no longer possible, resulting in permanent weakness, deformity, and paralysis. While the majority of the literature has focused on the site of nerve injury and speeding up neural regeneration, improved understanding of mechanisms that occur at the NMJ, downstream of the nerve injury, and more specifically at tSCs, is imperative to improve outcomes for patients affected by nerve injury. tSCs are especially dynamic after acute nerve injury, or denervation. Beginning at 3 days after motor nerve injury, tSCs extend elaborate cytoplasmic processes, which serve as platforms for axonal growth (Kang, Tian, & Thompson, 2003; Kang et al., 2014; Son & Thompson, 1995a , 1995b Woolf et al., 1992) . These processes extend from denervated to innervated synaptic sites, forming "bridges" to allow intact, terminal nerves to more rapidly reach denervated synapses (Figures 3 and 4) (Kang et al., 2003 (Kang et al., , 2014 . In addition to extending these processes that guide NMJ reinnervation, tSCs also acquire phagocytic activity, which is necessary to facilitate successful nerve regeneration (Birks, Katz, & Miledi, 1960; Duregotti et al., 2015) .
While tSC process extension after nerve injury has been described in several studies since 1992 (Kang et al., 2003 (Kang et al., , 2014 Son & Thompson, 1995a,b; Woolf et al., 1992) , our knowledge of the mechanisms driving tSC activation and tSC process extension beyond the area of the NMJ remain limited. The interaction between NRG1 and ErbB2 receptors, which are present on tSCs, may play a role in tSC process extension. The administration of exogenous NRG1 to neonatal muscles has been shown to activate ErbB2 receptors on tSCs, resulting in tSC process extension and the migration of tSCs away from endplates (Hayworth et al., 2006; Trachtenberg & Thompson, 1997) . Moreover, after denervation via a-latrotoxin, tSCs were activated by three mitochondrial alarmins: hydrogen peroxide, cytochrome c, and mitochondrial DNA. Additionally, inactivation of hydrogen peroxide delayed NMJ recovery after denervation, further suggesting the importance of this molecule on tSC activation and regeneration (Duregotti et al., 2015) . A subsequent study found that the CXCL12a-CXCR4 axis may also be important in NMJ regeneration after nerve injury. The authors show that tSCs produce CXCL12a, and that blockade of this ligand delays NMJ recovery following acute nerve injury (Negro et al., 2017) . Much remains to be learned regarding the mechanisms driving the activation and response of these cells after nerve injury. Future studies are warranted to identify the molecular mechanisms that drive tSC process extension and to investigate the functional consequences of tSC loss.
| F OCU S OF R EV I EW
Given the significance of tSCs on formation, maintenance, remodeling, and reinnervation of the NMJ, it is evident why they have been impli- (Lefebvre et al., 1995; McAndrew et al., 1997) .
| tSC abnormalities in SMA models
In severe SMA mouse models, transmission electron microscopy studies have determined that the diaphragm shows the earliest pathological changes. As early as postnatal day 4, diaphragmatic NMJs demonstrated variable amounts of disruption. Abnormal NMJs showed mitochondrial swellings in the axon terminals and muscle fibers. Moreover, tSCs displayed electron translucent, vacuole-like, cytoplasmic profiles (Voigt, Meyer, Baum, & Schumperli, 2010) . A subsequent study performed by the same group found a difference in S100 (marker for tSCs) staining intensity between partially innervated endplates in SMA versus wild-type mice; reduced or absent S100 staining was observed in partially innervated, but not fully innervated, endplates. The authors hypothesized that this effect could be due to loss of SC identity, as indicated by the poorly stained tSCs, or displacement of the tSCs by different cells. They further postulated that these morphological changes in tSCs may affect the overall maintenance and function of the corresponding NMJs (Neve, Trub, Saxena, & Schumperli, 2016) . A different SMA model that displays a less severe disease phenotype demonstrates less NMJ remodeling after paralysis and progressive tSC loss, further supporting the tSC roles of NMJ maintenance and remodeling (Murray, Beauvais, Bhanot, & Kothary, 2013) .
| Miller-Fisher syndrome
Miller-Fisher syndrome is a type of ascending peripheral neuropathy first described by Fisher in 1956. Known as a less common variant of GuillainBarr e, it is classically characterized by the triad of ophthalmoplegia, ataxia, and areflexia (Lo, 2007) . Most patients who are tested for Miller-Fisher syndrome possess serum positivity to antidisialoside antibodies that bind GQ1b (i.e., anti-GQ1b IgG), and these antibodies were first described as a serological marker for Miller-Fisher syndrome in 1992 (Chiba, Kusunoki, Shimizu, & Kanazawa, 1992) . GQ1b is a ganglioside that has been isolated in the paranodal regions of cranial nerves (Chiba, Kusunoki, Obata, Machinami, & Kanazawa, 1997; Teener, 2012) . Gangliosides are also enriched in presynaptic membranes and at the NMJ (Halstead et al., 2004; O'Hanlon et al., 2001; Wirguin et al., 2002) . While many cases of Willison, 2005). These antibodies bind complement and induce a complement-dependent paralysis resembling a-latrotoxin-induced paralysis (Halstead et al., 2004; O'Hanlon et al., 2001 ). This group later identified that antibodies reactive with ganglioside GD3 together with complement induced tSC death, but had no effect on nerve terminal electrophysiology or morphology (Halstead, Morrison, et al., 2005) . Using the methods described by Halstead and colleagues (Halstead, Morrison, et al., 2005) , our group has confirmed specific tSC ablation in rodent NMJs in vivo without damage to the presynaptic nerve ( Figure 5) . These experimental studies demonstrate that complement-mediated tSC injury occurs in autoimmune neuropathy and suggest that tSC damage may result in human neuromuscular disease (Overell & Willison, 2005) .
| Amyotrophic lateral sclerosis
ALS is a progressive neurodegenerative disorder that affects 2 in every 100,000 adults. Because of a rapid loss in upper and lower motor neurons, patients suffer from muscle weakness and paralysis leading to death from respiratory arrest (Ilieva & Maragakis, 2017) . Although an abundance of literature has been dedicated to understanding the role of motoneuron loss in the central nervous system, significantly less is known about the degenerative mechanisms that occur distally at the NMJ (Arbour, Vande Velde, & Robitaille, 2017) , even though NMJ denervation precedes motor neuron loss and is a major determinant of disease severity and progression (Fischer et al., 2004; Gould et al., 2006) . Because the NMJ is a complex structure composed of several different cell types, understanding how each cell type is affected by and responds to ALS may shed light on disease mechanisms and help to identify new therapeutic approaches.
| tSCs and ALS
One major cell type of investigative focus is the tSC, given its location and ability to regulate, maintain, and repair the NMJ (Auld & Robitaille, 2003; Feng & Ko, 2008; O'Malley et al., 1999; Robitaille et al., 1997) . Several studies have implicated glial cells in the peripheral nervous system in ALS pathophysiology (Arbour et al., 2015; Carrasco, Bahr, Seburn, & Pinter, 2016; Carrasco, Bichler, Seburn, & Pinter, 2010; De Winter et al., 2006; Keller, Gravel, & Kriz, 2009; Moloney, de Winter, & Verhaagen, 2014 improper NMJ repair and function during the disease course (Arbour et al., 2015) . In addition to these functional abnormalities, Carrasco and colleagues demonstrated that SOD1 G85R and SOD1 G93A mice had morphological tSC abnormalities that were evident even before denervation occurred, suggesting further that tSCs may contribute to motor terminal degeneration and denervation in these ALS models . A study performed by the same group demonstrated that tSC response after nerve injury was altered in mutant mice. Four days after nerve crush injury (i.e., denervation), tSCs at
NMJs of SOD1 mice lost S100 labeling to a far greater extent than did the tSCs of wild-type, age-matched control animals. Moreover, muscle reinnervation of SOD1 mice was delayed compared with wild-type animals, raising questions about the ability of tSCs to support normal nerve terminal function in these SOD1 mice (Carrasco, Bahr, et al., 2016 tSCs in presymptomatic mice versus in those with more progressive stages of the disease (De Winter et al., 2006) .
In addition to tSC abnormalities in rodent ALS models, a study by Bruneteau and colleagues showed altered tSC morphology in human samples from nine ALS patients of differing disease severity (Bruneteau et al., 2015) . tSC morphology was abnormal, with extensive cytoplasmic processes on confocal microscopy. Using ultrastructural methods, some NMJs appeared normal, while others demonstrated tSC processes abnormally invading the synaptic cleft, a finding that has been described in human samples from congenital myasthenic syndromes (see below). Given limited synaptic surface, tSC process intrusion into the synaptic cleft calls into question the ability for effective and efficient synaptic transmission in these abnormal-appearing NMJs.
| tSCs and other neuromuscular diseases
Abnormalities in tSCs have been found in other neuromuscular disease models. In mdx mice, the model for muscular dystrophy, tSCs located in the diaphragm extend processes, similar to those seen after denervation (Kang et al., 2003; Son & Thompson, 1995a,b) , but in a disorganized fashion and without bridge formation from denervated to innervated endplates (Personius & Sawyer, 2005) .
Instead, these tSC processes are directed away from the endplates, possibly impairing the ability of dystrophic muscle to undergo reinnervation, resulting in muscle weakness and paralysis (Marques, Pereira, Minatel, & Neto, 2006; Personius & Sawyer, 2005) . Insight into tSC abnormalities has been derived not only from rodent disease models but also from human clinical samples. For example, samples obtained from patients with congenital myasthenic syndrome caused by mutations in LAMB2 and agrin demonstrate invasion of tSC processes into the synaptic cleft or absent tSCs (Maselli et al., 2009; Nicole et al., 2014) . While these neuromuscular diseases differ in presentation and prognosis, they share defects in tSCs, suggesting a potential role for tSCs in the pathophysiology of these disorders.
| C ONC LUSI ON S
Despite the importance of tSCs on NMJ function and recovery, relatively little is known about these cells. tSCs are not only integral to synaptogenesis but also to the health, maintenance, and plasticity of the synapse during homeostasis and after denervation. Here, we review studies demonstrating morphological abnormalities of tSCs present in multiple rodent disease models, such as SMA, ALS, muscular dystrophy, and autoantibodies (plus complement) that selectively target and lyse tSCs in Miller-Fisher syndrome. Additionally, human samples from patients with ALS and congenital myasthenic syndromes contain tSC alterations, which may contribute to disease phenotype. The tSC abnormalities noted to date in these pathological states are summarized in Table 1 . tSCs are integral contributors to NMJ function and recovery and show numerous pathological changes. An improved understanding of tSCs may help decipher the pathogenesis of disease and provide new therapeutic targets for the many patients who suffer from peripheral nerve injuries and neuromuscular diseases.
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